179
Participants
Start Date
September 30, 2016
Primary Completion Date
April 30, 2018
Study Completion Date
September 30, 2018
High Dose Influenza vaccine
Licensed and FDA approved Fluzone HD vaccine to be administered to study participants
Adjuvanted Influenza vaccine
Licensed and FDA approved FluAd vaccine to be administered to study participants
Standard Dose Influenza vaccine
Licensed and FDA approved Fluvirin vaccine to be administered to study participants
Recombinant Influenza vaccine
Licensed and FDA approved FluBlok vaccine to be administered to study participants
Marshfield Clinic - Marshfield Center, Marshfield
Centers for Disease Control and Prevention
FED
Marshfield Clinic Research Foundation
OTHER